Navigation Links
Interleukin Genetics, Inc. Announces Positive Results from Clinical Study Evaluating Genetic Test's Impact on Weight Loss
Date:9/23/2009

genetic tests that empower consumers to prevent chronic diseases of aging and that assist pharmaceutical companies in the development and marketing of targeted therapeutics. The Company leverages its research, intellectual property and biomarker development experience to facilitate the emerging personalized health market. Interleukin Genetics is headquartered in Waltham, MA. For more information please visit www.ilgenetics.com.

Certain statements contained herein are "forward-looking" statements including statements regarding potential partnerships with weight management companies. Because such statements include risks and uncertainties, actual results may differ materially from those expressed or implied by such forward-looking statements. Factors that could cause actual results to differ materially from those expressed or implied by such forward-looking statements include, but are not limited to, the risk of market acceptance of the Company's products, the risk of technology and product obsolescence, delays in product development, the performance of commercial partners, the availability of adequate capital, the actions of competitors and other competitive risks, and those risks and uncertainties described in the Company's annual report on Form 10-K for the year ended December 31, 2008, quarterly reports on Form 10-Q and other filings with the Securities and Exchange Commission. The Company disclaims any obligation or intention to update these forward-looking statements.


'/>"/>
SOURCE Interleukin Genetics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Interleukin Genetics Presents Research Linking Vertebral Fractures to Gene Variations in Asian Women With Osteoporosis
2. Interleukin Genetics and Geisinger to Collaborate on Genetic Tests to Predict Weight Loss Success
3. Interleukin Genetics to Present Important New Findings at 2008 World Congress on Osteoarthritis
4. Interleukin Genetics Wins International Award for Outstanding Research Published in the Journal, Nutrition
5. Interleukin Genetics Launches Enhanced Heart Health Genetic Test Report Format
6. Video: The Journal, Human Genetics, Publishes Results Supporting Interleukin Genetics Heart Health Test
7. Genaera Announces MedImmune Initiation of Phase 2a Trial of Antibody Targeting Interleukin-9 in Patients with Asthma
8. MedImmune Advances Clinical Development of Antibody Targeting Interleukin-9 in Patients with Asthma
9. Phase 2a Multi-Dose Study Initiated by MedImmune in Patients With Asthma to Further Expand Anti-Interleukin-9 Program
10. Boston University and The Center for Human Genetics, Inc. Announce Change in Testing Services
11. Medivation Announces Initiation of Phase 3 Clinical Trial of MDV3100 in Advanced Prostate Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/30/2015)... 30, 2015 Eli Lilly and Company (NYSE: ... 7 to update the investment community and media on ... conjunction with the 75th American Diabetes Association® Scientific Sessions, ... business, including a review of the Phase III data ... the ADA meeting. The meeting will be ...
(Date:3/30/2015)... ISELIN, N.J. , March 30, 2015 /PRNewswire/ ... a medical device company focused on non-invasive continuous ... it has achieved its wireless mobile communication milestone, ... sensor to transmit data to any mobile platform. ... the strategic transformation of the Company,s technology from ...
(Date:3/30/2015)... , March 30, 2015  BioDelivery Sciences ... the primary efficacy endpoint in the Phase 3 ... placebo for the treatment of painful diabetic neuropathy ... endpoints showed statistically significant improvement over placebo.  In ... was observed.  The results of this trial provide ...
Breaking Medicine Technology:Lilly Announces Date for Diabetes Investor Meeting 2Echo Therapeutics, Inc. Achieves Wireless Mobile Communication Milestone 2Echo Therapeutics, Inc. Achieves Wireless Mobile Communication Milestone 3BioDelivery Sciences Announces Primary Endpoint in Phase 3 Study of Clonidine Topical Gel for Painful Diabetic Neuropathy Not Met, Though Encouraging Results Support Continued Development 2BioDelivery Sciences Announces Primary Endpoint in Phase 3 Study of Clonidine Topical Gel for Painful Diabetic Neuropathy Not Met, Though Encouraging Results Support Continued Development 3BioDelivery Sciences Announces Primary Endpoint in Phase 3 Study of Clonidine Topical Gel for Painful Diabetic Neuropathy Not Met, Though Encouraging Results Support Continued Development 4BioDelivery Sciences Announces Primary Endpoint in Phase 3 Study of Clonidine Topical Gel for Painful Diabetic Neuropathy Not Met, Though Encouraging Results Support Continued Development 5
... Colo., March 29, 2011 Encision Inc. (Pink Sheets: ... laparoscopic safety have become intensive topics of discussion in ... Surgery Magazine (March 2011).  The potential complications from laparoscopic ... probably prompted by a recent California case.  The issue ...
... 29, 2011 BioDrain Medical, Inc. (OTC Bulletin ... FDA cleared Streamway™ System for automated surgical fluid ... installation of its patented Streamway™ System in a ... several procedures utilizing the Streamway System and the ...
Cached Medicine Technology:Stray Energy Burns Become a "Hot Topic" in Recent Publications 2Stray Energy Burns Become a "Hot Topic" in Recent Publications 3BioDrain Medical, Inc. Completes Installation of Its Streamway™ Automated Surgical Fluid Disposal System in Minnesota Hospital 2BioDrain Medical, Inc. Completes Installation of Its Streamway™ Automated Surgical Fluid Disposal System in Minnesota Hospital 3
(Date:3/30/2015)... GenSight ®, provider of an Enterprise Portfolio Management ... Forrester Wave™: Strategic Planning For The [Business Technology] BT ... GenSight as a leader and gave the company the ... analytics, corporate strategy, assessment, direction and life cycle support ... Leaders category. , According to the report: GenSight ...
(Date:3/30/2015)... 2015 Follow us on ... are used as tracers to diagnose and treat ... is driven by the increase in the number ... cardiology, neurology, pulmonology, and oncology. Diagnostic radiopharmaceuticals represent ... of radioisotopes in diagnostic imaging. While cardiovascular and ...
(Date:3/30/2015)... El Segundo, CA (PRWEB) March 30, 2015 ... drug tests to accommodate the needs of every industry that ... As employers face compliance mandates or seek new ways to ... is adding new drug panels that will help detect substance ... “Certain industries have mandated drug tests,” said Corra Group Co-Founder, ...
(Date:3/30/2015)... (PRWEB) March 30, 2015 Cutting-edge doctors ... Health 2015 Conference because of the opportunities to present ... year’s conference will highlight parents of recovered children, who ... Mary Romaniec, will debut her book Victory over Autism: ... Family. Free copies of Victory over Autism will be ...
(Date:3/30/2015)... Bunion Bootie is a great option ... members, friends...and yourself and save. For a limited time only ... 10%, on top of discounts already offered when buying more ... The more Bunion Booties purchased, the more money is saved. ... Bunion Bootie can be worn comfortably and easily in almost ...
Breaking Medicine News(10 mins):Health News:GenSight Named as a Leader by Independent Research Firm in the Strategic Planning Market 2Health News:GenSight Named as a Leader by Independent Research Firm in the Strategic Planning Market 3Health News:Expanding Commercial Use in Nuclear Imaging Drives Demand for Radiopharmaceuticals, According to a New Report by Global Industry Analysts, Inc. 2Health News:Expanding Commercial Use in Nuclear Imaging Drives Demand for Radiopharmaceuticals, According to a New Report by Global Industry Analysts, Inc. 3Health News:Expanding Commercial Use in Nuclear Imaging Drives Demand for Radiopharmaceuticals, According to a New Report by Global Industry Analysts, Inc. 4Health News:Corra Group Adds New Employment Screening Drug Test Solutions for Clients in Every Industry 2Health News:Corra Group Adds New Employment Screening Drug Test Solutions for Clients in Every Industry 3Health News:AutismOne and Focus for Health Highlight Victory over Autism at Major Chicago Conference Following Autism Awareness Month 2Health News:AutismOne and Focus for Health Highlight Victory over Autism at Major Chicago Conference Following Autism Awareness Month 3Health News:Bunion Bootie, the Ultimate Solution for Bunion Relief, Offers Special Savings This Easter 2
... release is available in French . , ... support to recruit some of its best minds in ... family foundation has generously pledged $2.5 million to support ... University and the Universit du Qubec,s Institut national de ...
... for suspected pulmonary emboli (PE) is rapidly increasing amongst ... positive studies. This may be due to a failure ... with suspected PE, according to a study performed at ... Rhode Island Hospital, Providence, RI. , Current accepted ...
... Teva Announces First Event in Year of Affordable Healthcare ... consumer health group, recently reported that healthcare premiums in ... between 2000 and 2007. With healthcare costs ... claims being filed, many Americans are finding themselves driven ...
... Records Association (EHR Association) seeks broad stakeholder consensus by ... Act of 2009 (ARRA) as well as specific recommendations ... which will be used to determine eligibility for the ... and hospitals. "I,ve been pleased to have the ...
... M.D., has issued the,following press release: , ... a recent flurry of panic about,the H1N1 (swine influenza). ... cancelled. Some even suggested closing the border with Mexico,where ... back,and forth every day. The panic certainly was ...
... result in quick relief for communities that have been ... Feeding America and The Clorox Company ... communities hit by recent flooding in Eastern Kentucky and ... individuals and families are beginning the arduous task of ...
Cached Medicine News:Health News:Cole Foundation injects $2.5 million to bolster leukemia research 2Health News:ER physicians don't follow clinical guidelines for diagnosing possible pulmonary emboli 2Health News:As Healthcare Costs Skyrocket, Local Leaders Gather to Seek a Solution 2Health News:HIMSS Electronic Health Record Association Reaches Out to Key Stakeholders on 'Meaningful Use' of Certified EHRs 2Health News:HIMSS Electronic Health Record Association Reaches Out to Key Stakeholders on 'Meaningful Use' of Certified EHRs 3Health News:H1N1: What You Should Know 2Health News:H1N1: What You Should Know 3Health News:Feeding America Partner Support Expedites Disaster Relief and Recovery Efforts 2
... Anatomically Correct Design Is Unique Among All ... Gently Support The Lids Through An Anatomically Correct ... Contrasts With All Other Lid Speculums Which Pull ... The Tarsal Plate As They Open. Gentle ...
... Design Holds The Lens Securely During ... Blades Keep The Optic From Being ... Over Release Of The Optic.,Wide Jaw ... During Insertion.,Reusable, Autoclaveable, Made In The ...
... Designed To Dial An Exact Extension Of ... Maximum Visibility, With Titanium Handle & Spring. ... In Tissue, And Can Also Be Dialed ... Autoclaveable, Made In The USA, Handle Guaranteed ...
... Unique 23g Tube Allows Use Through ... A More Comfortable Approach To The ... The Capsule To Initiate And Complete ... In Weight For Improved Ergonomic Feel. ...
Medicine Products: